# US 2012/0253466 A1 · Methods and devices for the treatment of intervertebral discs disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253466 A1
- Document ID: US20120253466A1
- Status: Published application
- Kind: A1
- Application number: 13/076,645
- Filed: 2011-03-31
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: Warsaw Orthopedic, Inc.
- Inventors: Elaine Lee
- Web page: https://patentgrep.com/patent/US20120253466A1

## CPC

- A61F 2/441: {made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61F 2002/30064: {Coating or prosthesis-covering structure made of biodegradable material}
- A61F 2002/30581: {having a pocket filled with fluid, e.g. liquid}
- A61F 2002/30588: {filled with solid particles}
- A61F 2002/30677: {Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body}
- A61F 2002/3068: {the pharmaceutical product being in a reservoir}
- A61L 2430/38: for reconstruction of the spine, vertebrae or intervertebral discs
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Devices for the treatment of intervertebral discs are described. The devices, when implanted into the nucleus pulposus of an intervertebral disc, are specifically configured with an inert outer layer and an inner layer containing at least one chemonucleolysis agent so as to provide a delayed and controlled release of the chemonucleolysis agent from the inner layer into the disc. The implant can be an elongated solid body having a tapered or rounded insertion end having at least one therapeutic agent in the inner layer of the implant surrounded by an outer layer of inert material.

## Claims

### Claim 1

An intervertebral disc implant comprising
an inner layer comprising at least one chemonucleolysis agent; and
an inert outer inert layer disposed about the inner layer so as to fully encapsulate said inner layer, wherein said implant is configured so that release of said chemonucleolysis agent into tissue surrounding said implant is delayed until said inert outer layer bioerodes.

### Claim 2 (depends on 1)

The intervertebral disc implant of claim 1, wherein the inert outer layer includes a plurality of binder particles.

### Claim 3 (depends on 2)

The intervertebral disc implant of claim 2, wherein said plurality of binder particles of said inert outer layer degrades at different rates in order to prevent the release of said at least one chemonucleolysis agent from said inner layer for a predetermined amount of time.

### Claim 4 (depends on 1)

The intervertebral disc implant of claim 1 further comprising a coating disposed on an outermost surface of said outer layer wherein said coating must dissolve or degrade prior to the dissolution or degradation of said inert outer layer thereby slowing down the rate of release of said at least one chemonucleolysis agent from said inner layer.

### Claim 5 (depends on 1)

The intervertebral disc implant of claim 1, further comprising at least one therapeutic agent selected from the group consisting of anti-inflammatory agents, pain medication, growth factors, anti-bacterial agents and combinations thereof.

### Claim 6 (depends on 1)

The intervertebral disc implant of claim 1, wherein said inner layer includes a plurality of particles and wherein at least some of the particles comprise said at least one chemonucleolysis agent.

### Claim 7 (depends on 6)

The intervertebral disc implant of claim 6, wherein the particles comprising said at least one chemonucleolysis agent have an average diameter of about 0.5 to about 250 μm.

### Claim 8 (depends on 1)

The intervertebral disc implant of claim 1, wherein said at least one chemonucleolysis agent is selected from the group consisting of chymopapain, collagenase, chondroitinase-ABC, hyaluronidase, human proteolytic enzymes, and polycationic substances.

### Claim 9 (depends on 5)

The intervertebral disc implant of claim 5, wherein said inner layer includes a plurality of particles and wherein at least some of the particles comprise said at least one therapeutic agent of claim 5.

### Claim 10 (depends on 1)

The intervertebral disc implant of claim 1, wherein said inner layer is a liquid, gel, hydrogel, emulsion, particulate or solid.

### Claim 11 (depends on 1)

The intervertebral disc implant of claim 1, further comprising a marker for tracking the location of said intervertebral disc implant when placed into the nucleus pulposus of an intervertebral disc.

### Claim 12 (depends on 11)

The intervertebral disc implant of claim 11, wherein said marker is an x-ray marker or radio-opaque marker.

### Claim 13 (depends on 5)

The intervertebral disc implant of claim 5, wherein said pain medication is selected from the group consisting of codeine, propoxyphene, hydrocodone, oxycodone and combinations thereof.

### Claim 14 (depends on 5)

The intervertebral disc implant of claim 5, wherein said growth factor is selected from the group consisting of a transforming growth factor-beta protein, a bone morphogenetic protein, a fibroblast growth factor, a platelet-derived growth factor, an insulin-like growth factor and combinations thereof.

### Claim 15 (depends on 12)

The intervertebral disc implant of claim 12, wherein said x-ray marker comprises barium sulfate, platinum or tantalum.

### Claim 16 (depends on 1)

A method for treating at least one condition of an intervertebral disc in a patient in need of such treatment, said method comprising:
placing said intervertebral disc implant of claim 1 into the nucleus pulposus of an intervertebral space of said patient, wherein said placing releases said chemonucleolysis agent into the nucleus pulposus surrounding the implant after said inert outer layer bioerodes, thereby proteolytically degrading the nucleus pulposus.

### Claim 17 (depends on 16)

The method of claim 16, wherein the placing of said implant into the intervertebral space comprises:
inserting a needle/trocar assembly into the intervertebral space such that the inserted end of the trocar is inside the nucleus pulposus of an intervertebral disc;
removing said needle;
placing said implant into said trocar;
pushing said implant into the nucleus pulposus of the intervertebral disc;
and removing the trocar.

### Claim 18 (depends on 11)

A method for treating at least one condition of an intervertebral disc in a patient in need of such treatment and tracking said implant for proper placement, said method comprising:
(a) placing said intervertebral disc implant of claim 11 into an intervertebral space of said patient,
(b) determining the position of said intervertebral disc implant by detecting a location of said x-ray marker or radio-opaque marker using an imaging device and determining whether said location of said implant is correct, if said implant is not in the correct location proceeding to step (c) and if said implant is in the correct location proceeding to step (d);
(c) removing said implant from said intervertebral disc and reinserting said implant in a different location in said intervertebral disc from which said implant was removed and repeating step (b); and
(d) allowing said outer layer of said implant to bioerode and release said chemonucleolysis agent in said inner layer to the nucleus pulposus surrounding said implant, thereby treating said condition of said patient.

### Claim 19 (depends on 18)

The method of claim 18,
wherein the placing of said implant into the intervertebral space of step (a) comprises inserting a needle/trocar assembly into the intervertebral space such that the inserted end of the trocar is inside the nucleus pulposus of an intervertebral disc;
removing said needle;
placing said implant into said trocar;
pushing said implant into the nucleus pulposus of the intervertebral disc and determining the position of said intervertebral disc implant by detecting the position according to step (b); and
removing the trocar upon the completion of step (d).

### Claim 20 (depends on 18)

The method of claim 18 wherein said implant further comprises at least one therapeutic agent selected from the group consisting of anti-inflammatory agents, pain medication, growth factors, anti-bacterial agents and combinations thereof.
